Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Franck‐Emmanuel Nicolini"'
Autor:
Amine Belhabri, Mael Heiblig, Stephane Morisset, Liliana Vila, Clémence Santana, Emmanuelle Nicolas‐Virelizier, Sandrine Hayette, Isabelle Tigaud, Adriana Plesa, Hélène Labussiere‐Wallet, Mohamad Sobh, Anne‐Sophie Michallet, Balsat Marie, Franck‐Emmanuel Nicolini, Yann Guillermin, Fossard Gaëlle, Laure Lebras, Philippe Rey, Lucie Jauffret‐Bertholon, Marie‐Charlotte Laude, Loron Sandrine, Mauricette Michallet
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 16929-16944 (2023)
Abstract Background t‐AML occurs after a primary malignancy treatment and retains a poor prognosis. Aims To determine the impact of primary malignancies, therapeutic strategies, and prognostic factors on clinical outcomes of t‐AML. Results A tota
Externí odkaz:
https://doaj.org/article/5ada555af80042d89c8cd782e7628bd6
Autor:
Franck-Emmanuel Nicolini, Françoise Huguet, Lynn Huynh, Churong Xu, Christophe Bouvier, Aurore Yocolly, Gabriel Etienne
Publikováno v:
Cancers, Vol 15, Iss 16, p 4161 (2023)
This retrospective chart review study investigated the clinical burden of adult patients with chronic-phase chronic myeloid leukemia (CP-CML) treated at three centers in France (2006–2021) who failed on two or more tyrosine kinase inhibitors (TKIs;
Externí odkaz:
https://doaj.org/article/b3aa639722a24f55a46bfec5fc336434
Autor:
Sandrine Jeanpierre, Kawtar Arizkane, Supat Thongjuea, Elodie Grockowiak, Kevin Geistlich, Lea Barral, Thibault Voeltzel, Anissa Guillemin, Sandrine Gonin-Giraud, Olivier Gandrillon, Franck-Emmanuel Nicolini, Adam J. Mead, Véronique Maguer-Satta, Sylvain Lefort
Publikováno v:
Haematologica, Vol 106, Iss 1 (2020)
Chronic myelogenous leukemia arises from the transformation of hematopoietic stem cells by the BCR-ABL oncogene. Though transformed cells are predominantly BCR-ABL-dependent and sensitive to tyrosine kinase inhibitor treatment, some BMPR1B+ leukemic
Externí odkaz:
https://doaj.org/article/75843c79b30b468e9f827d7e14a5515e
Autor:
Audrey Bidet, Stéphanie Dulucq, Thomas Smol, Alice Marceau-Renaut, Stéphane Morisset, Valérie Coiteux, Marie-Pierre Noël-Walter, Franck-Emmanuel Nicolini, Isabelle Tigaud, Isabelle Luquet, Stéphanie Struski, Baptiste Gaillard, Dominique Penther, Sylvie Tondeur, Nathalie Nadal, Eric Hermet, Lauren Véronèse, Delphine Réa, Carine Gervais, Olivier Theisen, Christine Terré, Pascale Cony-Makhoul, Christine Lefebvre, Jean-Baptiste Gaillard, Isabelle Radford, Anne-Laure Vervaeke, Carole Barin, Elise Chapiro, Florence Nguyen-Khac, Gabriel Etienne, Claude Preudhomme, François Xavier Mahon, Catherine Roche-Lestienne
Publikováno v:
Haematologica, Vol 104, Iss 6 (2019)
Clonal chromosome abnormalities in Philadelphia-negative cells could concern chronic myeloid leukemia patients treated by tyrosine kinase inhibitors. The European LeukemiaNet distinguishes -7/del(7q) abnormalities as a “warning”. However, the imp
Externí odkaz:
https://doaj.org/article/ae0e75dd0d014cd59b335fb1c0404e5d
Autor:
Gabriel Etienne, Stéphanie Dulucq, Franck-Emmanuel Nicolini, Stéphane Morisset, Marie-Pierre Fort, Anna Schmitt, Madeleine Etienne, Sandrine Hayette, Eric Lippert, Caroline Bureau, Isabelle Tigaud, Didier Adiko, Gérald Marit, Josy Reiffers, François-Xavier Mahon
Publikováno v:
Haematologica, Vol 99, Iss 3 (2014)
Sustained imatinib treatment in chronic myeloid leukemia patients can result in complete molecular response allowing discontinuation without relapse. We set out to evaluate the frequency of complete molecular response in imatinib de novo chronic phas
Externí odkaz:
https://doaj.org/article/d60de4bcb051487386bc5cf4910d8863
Autor:
Stephanie, Dulucq, Sandrine, Hayette, Jean-Michel, Cayuela, Frédéric, Bauduer, Kaddour, Chabane, Patrice, Chevallier, Pascale, Cony-Makhoul, Pascale, Flandrin-Gresta, Caroline Le, Jeune, Yannick Le, Bris, Laurence, Legros, Hervé, Maisonneuve, Lydia, Roy, Francois-Xavier, Mahon, Ivan, Sloma, Delphine, Rea, Franck Emmanuel, Nicolini
Publikováno v:
Haematologica. 107:2944-2949
Publikováno v:
Bulletin du Cancer. 109:862-872
Autor:
François-Xavier Mahon, Gabriel Etienne, Joëlle Guilhot, Fabrice Larosa, François Guilhot, Emilie Cayssials, Marc G. Berger, Bruno Villemagne, Tawfiq Henni, Patricia Zunic, Bertrand Joly, Henry Jardel, Juliana Martiniuc, Hyacinthe Johnson-Ansah, Pascal Turlure, Jean-Christophe Ianotto, Martine Gardembas, Jixing Liu, Laurence Legros, Agnès Guerci-Bresler, Delphine Rea, Philippe Rousselot, Pascal Lenain, Viviane Dubruille, Bruno Varet, Valérie Coiteux, Françoise Rigal-Huguet, Martine Escoffre-Barbe, Aude Charbonnier, Pascale Cony-Makhoul, Lisa Boureau, Stéphanie Dulucq, Franck Emmanuel Nicolini
Supplemental table 1: Sequence of hydrolysis probes and primers used for the ddPCR.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f7726c8b0b1bc74397891352517d7e2
https://doi.org/10.1158/1078-0432.22471089.v1
https://doi.org/10.1158/1078-0432.22471089.v1
Autor:
François-Xavier Mahon, Gabriel Etienne, Joëlle Guilhot, Fabrice Larosa, François Guilhot, Emilie Cayssials, Marc G. Berger, Bruno Villemagne, Tawfiq Henni, Patricia Zunic, Bertrand Joly, Henry Jardel, Juliana Martiniuc, Hyacinthe Johnson-Ansah, Pascal Turlure, Jean-Christophe Ianotto, Martine Gardembas, Jixing Liu, Laurence Legros, Agnès Guerci-Bresler, Delphine Rea, Philippe Rousselot, Pascal Lenain, Viviane Dubruille, Bruno Varet, Valérie Coiteux, Françoise Rigal-Huguet, Martine Escoffre-Barbe, Aude Charbonnier, Pascale Cony-Makhoul, Lisa Boureau, Stéphanie Dulucq, Franck Emmanuel Nicolini
Purpose:Tyrosine kinase inhibitor (TKI) discontinuation is an emerging goal in chronic myelogenous leukemia (CML) management and several studies have demonstrated the feasibility of safely stopping imatinib. A sustained deep molecular response on lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81957a08b236baabd637b053f89787a7
https://doi.org/10.1158/1078-0432.c.6527778
https://doi.org/10.1158/1078-0432.c.6527778
Autor:
Marie Balsat, Vincent Alcazer, Gabriel Etienne, Françoise Huguet, Marc Berger, Emilie Cayssials, Aude Charbonnier, Martine Escoffre-Barbe, Hyacinthe Johnson-Ansah, Laurence Legros, Lydia Roy, Alain Delmer, Jean-Christophe Ianotto, Corentin Orvain, Fabrice Larosa, Mathieu Meunier, Shanti Amé, Annalisa Andreoli, Pascale Cony-Makhoul, Stéphane Morisset, Isabelle Tigaud, Delphine Rea, Franck Emmanuel Nicolini
Publikováno v:
Leukemia Research. 130:107308